{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-041330","form_type":"8-K","ticker":"CELU","cik":"0001752828","company_name":"Celularity Inc","filed_at":"2024-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.469566+00:00","generated_at":"2026-05-30T13:53:16.520901+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Celularity acquires Rebound placental matrix product from Sequence LifeScience for $5.5M","bullets":["Total consideration $5.5M: $1M upfront cash, up to $4M monthly milestone payments (20% of net sales), and $500K credit.","Exclusive supply agreement with Sequence for min 6 months; Celularity intends to transfer manufacturing in-house.","H1 2024 biomaterial sales >$24M, exceeding full year 2023; Rebound expected to contribute in Q4 2024.","Rebound is full-thickness placental-derived allograft matrix for wound care and soft tissue repair."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-041330","json":"https://secwatch.observer/filing/0001493152-24-041330.json","markdown":"https://secwatch.observer/filing/0001493152-24-041330.md","text":"https://secwatch.observer/filing/0001493152-24-041330.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1752828/000149315224041330/0001493152-24-041330-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1752828/000149315224041330/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:53:16.520901+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}